An in vivo model was used to verify the inhibitory effect of TRIM32 on CRC using tumor volume and weight measurement, Hematoxylin and eosin (H&E) staining, and Ki67 immunohistochemistry (IHC) staining of tumor tissue. The gene discussed is MKI67; the disease is colorectal carcinoma.